Amy Marbaugh, RN, BSN, MS, of the Kidney Cancer Association, explains why it's critical to raise awareness. The survey assessed how testicular cancer impacted fertility, socioeconomic status, and sexual health in young survivors. Psychosocial care and support are critical parts of cancer care, according to the International Psycho-Oncology Society. The use of the blood-based test, which was validated in the SEPTA trial, could reduce the number of biopsies needed. These measurements can help clinicians understand if a treatment is making a patient's life better, longer, or both. Learn how oncology nurses can be leaders in building oncofertility conversations and programs. Christopher Wallis, MD, PhD, FRCSC, and Karen Hoffman, MD, MHSc, MPH, discuss patient-reported outcomes from the trial. Ongoing work is exploring the relationship between resilience and different domains of frailty. Learn how a team implemented a program to address challenges experienced by patients with prostate cancer. A new study highlights the need for “further efforts and policy changes” to improve access to end-of-life care. The rash management protocol was implemented in the phase II Apa-RP study. Oncology nurses frequently encounter patients grappling with the challenging combination of poor appetite and weight loss. Certain patients are less likely to use hospice services, but oncology nurses can help ensure the option is made available. The novel monoclonal antibody targeted B7-H3 with high success and low incidence of adverse events. Avelumab combined with current best supportive care improves progression-free and overall survival in patients with mUC. Though it takes longer, robotic-assisted radical cystectomy leads to fewer transfusions and less blood loss. A study attempted to explore the role of palliative care in facilitating advance directive discussions among veterans. Researchers sought the answer in a study that examined aggressive end-of-life care for patients with MRCC. A study looks at previous adjuvant therapy treatments to determine the future of adjuvant therapy use for localized RCC. Cannabis use is associated with a lower risk of bladder cancer and RCC in women, and lower risk of prostate cancer in men.